25-Hydroxyvitamin D in the Range of 20 to 100 Ng/mL and Incidence of Kidney Stones

Overview

Journal Am J Public Health

Specialty Public Health

Date 2013 Oct 19

PMID 24134366

Citations 12

Authors

Stacie Nguyen

Leo Baggerly

Christine French

Robert P Heaney

Edward D Gorham

Cedric F Garland

Affiliations

Soon will be listed here.

Abstract

Objectives: Increasing 25-hydroxyvitamin D serum levels can prevent a wide range of diseases. There is a concern about increasing kidney stone risk with vitamin D supplementation. We used GrassrootsHealth data to examine the relationship between vitamin D status and kidney stone incidence.

Methods: The study included 2012 participants followed prospectively for a median of 19 months. Thirteen individuals self-reported kidney stones during the study period. Multivariate logistic regression was applied to assess the association between vitamin D status and kidney stones.

Results: We found no statistically significant association between serum 25-hydroxyvitamin D and kidney stones (P = .42). Body mass index was significantly associated with kidney stone risk (odds ratio = 3.5; 95% confidence interval = 1.1, 11.3).

Conclusions: We concluded that a serum 25-hydroxyvitamin D level of 20 to 100 nanograms per milliliter has no significant association with kidney stone incidence.

Citing Articles

Associations between 25-hydroxyvitamin D/calcium/alkaline phosphatase levels and the risk of developing kidney stones: Results from NHANES (2013-2018)-based and Mendelian randomization studies.

Ran Y, Liu Z, Ma H, Li C, Zhou J, Li D Medicine (Baltimore). 2025; 104(4):e41323.

PMID: 39854758 PMC: 11771664. DOI: 10.1097/MD.0000000000041323.

Association between serum 25-hydroxyvitamin D concentrations and kidney stone: a cohort study in the UK Biobank.

Gao C, Gao M, Huang Y Int Urol Nephrol. 2024; 56(11):3585-3594.

PMID: 38842659 DOI: 10.1007/s11255-024-04111-8.

Associations between lumbar bone mineral density, serum 25-hydroxyvitamin D and history of kidney stones in adults aged 30-69 years in the USA (NHANES 2011-2018).

Li Z, Li L, Zheng J, Li M, Wu S, Xin K BMJ Open. 2023; 13(5):e070555.

PMID: 37221021 PMC: 10231023. DOI: 10.1136/bmjopen-2022-070555.

UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Bhojani N, Bjazevic J, Wallace B, Lee L, Kaler K, Dion M Can Urol Assoc J. 2022; 16(6):175-188.

PMID: 35623003 PMC: 9245965. DOI: 10.5489/cuaj.7872.

Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications.

McCullough P, McCullough W, Lehrer D, Travers J, Repas S Nutrients. 2021; 13(5).

PMID: 33947070 PMC: 8146035. DOI: 10.3390/nu13051511.

References

Wactawski-Wende J, Kotchen J, Anderson G, Assaf A, Brunner R, OSullivan M . Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006; 354(7):684-96. DOI: 10.1056/NEJMoa055222. View

Taylor E, Stampfer M, Curhan G . Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004; 15(12):3225-32. DOI: 10.1097/01.ASN.0000146012.44570.20. View

Garland C, Gorham E, Mohr S, Grant W, Giovannucci E, Lipkin M . Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007; 103(3-5):708-11. DOI: 10.1016/j.jsbmb.2006.12.007. View

Curhan G, Willett W, Knight E, Stampfer M . Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004; 164(8):885-91. DOI: 10.1001/archinte.164.8.885. View

Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T . A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta. 2009; 403(1-2):145-51. DOI: 10.1016/j.cca.2009.02.005. View

Wortsman J, Matsuoka L, Chen T, Lu Z, Holick M . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72(3):690-3. DOI: 10.1093/ajcn/72.3.690. View

Jackson R, LaCroix A, Gass M, Wallace R, Robbins J, Lewis C . Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354(7):669-83. DOI: 10.1056/NEJMoa055218. View

Garland C, French C, Baggerly L, Heaney R . Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011; 31(2):607-11. View

Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G . Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr. 2010; 49(7):401-7. DOI: 10.1007/s00394-010-0098-7. View

10.

Munger K, Levin L, Hollis B, Howard N, Ascherio A . Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006; 296(23):2832-8. DOI: 10.1001/jama.296.23.2832. View

11.

Gallagher J, Sai A, Templin 2nd T, Smith L . Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012; 156(6):425-37. DOI: 10.7326/0003-4819-156-6-201203200-00005. View

12.

Johnson C, Wilson D, OFallon W, Malek R, Kurland L . Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979; 16(5):624-31. DOI: 10.1038/ki.1979.173. View

13.

Heaney R . Calcium supplementation and incident kidney stone risk: a systematic review. J Am Coll Nutr. 2008; 27(5):519-27. DOI: 10.1080/07315724.2008.10719734. View

14.

Gorham E, Garland C, Burgi A, Mohr S, Zeng K, Hofflich H . Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case-control study. Diabetologia. 2012; 55(12):3224-7. DOI: 10.1007/s00125-012-2709-8. View

15.

Curhan G, Willett W, Speizer F, Spiegelman D, Stampfer M . Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997; 126(7):497-504. DOI: 10.7326/0003-4819-126-7-199704010-00001. View

16.

Drincic A, Armas L, Van Diest E, Heaney R . Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012; 20(7):1444-8. DOI: 10.1038/oby.2011.404. View

17.

Hathcock J, Shao A, Vieth R, Heaney R . Risk assessment for vitamin D. Am J Clin Nutr. 2007; 85(1):6-18. DOI: 10.1093/ajcn/85.1.6. View

18.

Garland C, Gorham E, Mohr S, Garland F . Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009; 19(7):468-83. DOI: 10.1016/j.annepidem.2009.03.021. View

19.

Heaney R, Davies K, Chen T, Holick M, Barger-Lux M . Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2002; 77(1):204-10. DOI: 10.1093/ajcn/77.1.204. View

20.

Vieth R, Chan P, MacFarlane G . Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001; 73(2):288-94. DOI: 10.1093/ajcn/73.2.288. View